331A — Medix Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapContrarian

Annual income statement for Medix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Tanshin
Standards:	JAS	JAS	—
Status:	Final	Final	Final
Revenue
Total Revenue	4,273	4,180	4,162
Cost of Revenue
Gross Profit	3,692	3,738	3,728
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,667	3,395	3,359
Operating Profit	606	785	803
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	637	788	952
Provision for Income Taxes
Net Income After Taxes	402	489	804
Net Income Before Extraordinary Items
Net Income	402	489	804
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	402	489	804
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	63.6	61.8	103
Dividends per Share